Trulieve Cannabis (TCNNF) Other financing activities (2022 - 2026)

Trulieve Cannabis (TCNNF) recorded quarterly Other financing activities of $1.3 million in Q1 2026, up 142.9% quarter-over-quarter from -$3.0 million in Q4 2024.

Trulieve Cannabis (TCNNF) Other financing activities (2022 - 2026) Analysis & Trends

Trulieve Cannabis' Other financing activities history runs 3 years deep, the most recent figure standing at $1.3 million for Q1 2026.

  • In Q1 2026, Other financing activities changed N/A year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at -$1.7 million (up 42.9% YoY), while the FY2025 annual figure was $3.3 million, changed N/A from the prior year.
  • Other financing activities was $1.3 million for Q1 2026 at Trulieve Cannabis, up from -$3.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $3.0 million in Q1 2024 to a low of -$3.0 million in Q4 2024.
  • Historically, Other financing activities has averaged $214500.0 across 3 years, with a median of $94500.0 in 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Trulieve Cannabis - - 170.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.29 Mn
Mar 31, 2026 1.29 Mn
Dec 31, 2024 -3.00 Mn
Dec 31, 2024 -3.00 Mn
Mar 31, 2024 3.00 Mn
Mar 31, 2024 3.00 Mn
Dec 31, 2022 -189,000.00
Dec 31, 2022 -189,000.00
Jun 30, 2022 170,000.00
Jun 30, 2022 170,000.00
Mar 31, 2022 19,000.00
Mar 31, 2022 19,000.00